Sun Pharma does it again! - Views on News from Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

Sun Pharma does it again!

Apr 19, 2001

Sun Pharma has done it again. Mainly on the back of a better product mix, the company reported an increase in net profit of 49.2% against less than proportionate growth in topline. This numbers exclude the merger with Pradeep Drug Company Ltd and also Sun Pharmaceutical Advanced Research Centre Ltd, which is the research arm of the company.

(Rs m) FY00 FY01 Change
Sales 4,785.5 6,132.3 28.1%
Other Income 36.3 67.4 85.7%
Expenditure 3,717.5 4,625.1 24.4%
Operating Profit (EBDIT) 1,068.0 1,507.2 41.1%
Operating Profit Margin (%) 22.3% 24.6%  
Interest 14.4 (20.9) -245.1%
Depreciation 126.9 151.6 19.5%
Profit before Tax 963.0 1,443.9 49.9%
Other Adjustments   -  
Tax 58.7 94.7 61.3%
Profit after Tax/(Loss) 904.3 1,349.2 49.2%
Net profit margin (%) 18.9% 0.2  
No. of Shares (eoy) (m) 15.4 46.8  
Diluted Earnings per share 19.3 28.9  
P/E   18.3  

The Company's focus on high margin theraputic segments seems to be paying off as is evident from considerable improvement in operating margins. The operating margins have shown an improvement of more than 200 basis points.

At Rs 528 the comapany trades on a multiple of 18.3x FY01 earnings. The three year average P/E for the company is 23.8x.


Equitymaster requests your view! Post a comment on "Sun Pharma does it again!". Click here!

  

More Views on News

SUN PHARMA Announces Quarterly Results (4QFY20); Net Profit Down 31.6% (Quarterly Result Update)

May 28, 2020 | Updated on May 28, 2020

For the quarter ended March 2020, SUN PHARMA has posted a net profit of Rs 5 bn (down 31.6% YoY). Sales on the other hand came in at Rs 82 bn (up 14.3% YoY). Read on for a complete analysis of SUN PHARMA's quarterly results.

SUN PHARMA Announces Quarterly Results (3QFY20); Net Profit Down 29.8% (Quarterly Result Update)

Feb 7, 2020 | Updated on Feb 7, 2020

For the quarter ended December 2019, SUN PHARMA has posted a net profit of Rs 10 bn (down 29.8% YoY). Sales on the other hand came in at Rs 82 bn (up 5.4% YoY). Read on for a complete analysis of SUN PHARMA's quarterly results.

SUN PHARMA 2018-19 Annual Report Analysis (Annual Result Update)

Aug 6, 2019 | Updated on Aug 6, 2019

Here's an analysis of the annual report of SUN PHARMA for 2018-19. It includes a full income statement, balance sheet and cash flow analysis of SUN PHARMA. Also includes updates on the valuation of SUN PHARMA.

SUN PHARMA 2017-18 Annual Report Analysis (Annual Result Update)

Dec 20, 2018 | Updated on Dec 20, 2018

Here's an analysis of the annual report of SUN PHARMA for 2017-18. It includes a full income statement, balance sheet and cash flow analysis of SUN PHARMA. Also includes updates on the valuation of SUN PHARMA.

More Views on News

Most Popular

Why We Picked This Small-cap Stock for Our Hidden Treasure Subscribers (Profit Hunter)

Sep 17, 2020

This leading household brand will profit big time in a post covid world.

My Top Stock to Buy in this Market Selloff (Profit Hunter)

Sep 22, 2020

The recent correction offers a great opportunity to buy this high conviction smallcap stock.

Can the Nifty Fall to 10,200? (Fast Profits Daily)

Sep 24, 2020

The Nifty has reached an important support level today. If it breaks then we could see further downside.

What Do the Charts Say About Buying Smallcaps Now? (Fast Profits Daily)

Sep 18, 2020

Everyone seems to be excited about buying smallcaps now...but is it the right thing to do? What do the charts tell us? Find out in this video...

More

Covid-19 Proof
Multibagger Stocks

Covid19 Proof Multibaggers
Get this special report, authored by Equitymaster's top analysts now!
We will never sell or rent your email id.
Please read our Terms

SUN PHARMA SHARE PRICE


Sep 29, 2020 (Close)

TRACK SUN PHARMA

  • Track your investment in SUN PHARMA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

SUN PHARMA 8-QTR ANALYSIS

COMPARE SUN PHARMA WITH

MARKET STATS